The Resource Reducing and preventing cardiovascular disease : rationale and evidence provided by HOPE : proceedings of a symposium at the XXII Congress of the European Society of Cardiology in Amsterdam, August 2000, guest editor, Peter Sleight ; [chaired by P. Sleight, S. Yusuf]

Reducing and preventing cardiovascular disease : rationale and evidence provided by HOPE : proceedings of a symposium at the XXII Congress of the European Society of Cardiology in Amsterdam, August 2000, guest editor, Peter Sleight ; [chaired by P. Sleight, S. Yusuf]

Label
Reducing and preventing cardiovascular disease : rationale and evidence provided by HOPE : proceedings of a symposium at the XXII Congress of the European Society of Cardiology in Amsterdam, August 2000
Title
Reducing and preventing cardiovascular disease
Title remainder
rationale and evidence provided by HOPE : proceedings of a symposium at the XXII Congress of the European Society of Cardiology in Amsterdam, August 2000
Statement of responsibility
guest editor, Peter Sleight ; [chaired by P. Sleight, S. Yusuf]
Contributor
Subject
Genre
Language
eng
Member of
Cataloging source
MMU
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
bibliography
http://library.link/vocab/relatedWorkOrContributorDate
  • 1952-
  • 2000 :
http://library.link/vocab/relatedWorkOrContributorName
  • Sleight, Peter
  • Yusuf, Salim
  • European Society of Cardiology
  • Medicom International Incorporated
Series statement
International journal of clinical practice
Series volume
Supplement 117, January 2001
http://library.link/vocab/subjectName
  • Cardiovascular Diseases
  • Cardiovascular Diseases
  • Ramipril
  • Vitamin E
Label
Reducing and preventing cardiovascular disease : rationale and evidence provided by HOPE : proceedings of a symposium at the XXII Congress of the European Society of Cardiology in Amsterdam, August 2000, guest editor, Peter Sleight ; [chaired by P. Sleight, S. Yusuf]
Instantiates
Publication
Note
  • Cover title
  • "Produced as a supplement to the International Journal of Clinical Practice (incorporating the British Journal of Clinical Practice) by Medicom International"--T.p. verso
  • "A Medicom International Publication"
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Vascular protection: current possibilities and future perspectives -- Angiotensin-converting enzyme inhibitors as a new frontier in cardiovascular prevention: results of the HOPE trial -- Diabetes and the HOPE study: implications for macrovascular and microvascular disease -- Modifying the natural history of atherosclerosis: the SECURE trial -- Pharmacoeconomic impact of HOPE -- Future perspectives and implications -- Reducing and preventing cardiovascular disease: discussion
Control code
46798337
Dimensions
28 cm
Extent
24 pages
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations
Label
Reducing and preventing cardiovascular disease : rationale and evidence provided by HOPE : proceedings of a symposium at the XXII Congress of the European Society of Cardiology in Amsterdam, August 2000, guest editor, Peter Sleight ; [chaired by P. Sleight, S. Yusuf]
Publication
Note
  • Cover title
  • "Produced as a supplement to the International Journal of Clinical Practice (incorporating the British Journal of Clinical Practice) by Medicom International"--T.p. verso
  • "A Medicom International Publication"
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Vascular protection: current possibilities and future perspectives -- Angiotensin-converting enzyme inhibitors as a new frontier in cardiovascular prevention: results of the HOPE trial -- Diabetes and the HOPE study: implications for macrovascular and microvascular disease -- Modifying the natural history of atherosclerosis: the SECURE trial -- Pharmacoeconomic impact of HOPE -- Future perspectives and implications -- Reducing and preventing cardiovascular disease: discussion
Control code
46798337
Dimensions
28 cm
Extent
24 pages
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations

Library Locations

    • J. Otto Lottes Health Sciences LibraryBorrow it
      1 Hospital Dr, Columbia, MO, 65201, US
      38.939544 -92.328377
Processing Feedback ...